Post by Deanne Jenkyns on Apr 13, 2007 18:42:57 GMT 1
Appealing for funding for drugs on exceptionality Grounds
Introduction
If you are a patient who’s been told by your oncologist that you could benefit from a particular drug, but your PCT won’t give it to you because it’s “too expensive” you can apply – with the help of your GP or Oncologist or both – to your primary care trust (PCT) For “exceptional funding” to pay for it.
A special PCT fund
PCT’s have to maintain a fund for exception cases, outside of their overall budget. In these cases, they cannot take into account whether the cost of the drug affects their overall budget – which is usually in deficit these days – or whether you the patient can afford to pay for the drug yourself.
When you can apply
An application for exceptional funding, which some PCTs call “special funding” or “special circumstances” can be made for drugs that haven’t been recommended – usually on the grounds of cost – by the National Institute for Health and Clinical Excellence (NICE). This currently applies, for example to biological agents such as Tarceva. NICE recommendations are guidance not law, so PCTs do not have to follow them.
An application can also be made in the cases where NICE hasn’t made a recommendation about a drug yet – either positive or negative – or about it’s use in a particular setting (e.g. first line combination with other treatments). In these circumstances, the PCT will have to decide if the drug can or cannot be prescribed.
Applications and appeals
The terms PCT’s use for applications can be confusing. Some applications are considered as just that and if refused they may be followed up by an appeal to an internal PCT panel. However, some PCTs refer to the initial application itself as an appeal, presumably because medical practitioners are told in advance not to apply for funding for patients. As they would be turned down anyway.
To make it even more confusing, some appeals can become fresh applications if new information about a case becomes available. In any event, you have the right to apply with the help of your GP or oncologist or both, and you should do so in writing. If you are too ill to peruse the application/appeal yourself, you can nominate someone to act on your behalf, but you should provide them with written confirmation that you give your permission in order to satisfy the PCT.
The PCTs response
There appears to be no set procedure followed by PCTs in responding to these applications, including in how long they take to reply. While there are some set deadlines, it appears that the PCTs treat each case individually and the more pressing or urgent the matter, the more likely they are to respond quickly.
On average, PCTs tend to respond to an application letter within a week. They then take up to a further two weeks to collect all the material they need and convene a panel of around five people to consider the application. However, that process can take up to six weeks in some more complicated cases and it is, of course, vital to get your medical practitioner’s written recommendation for the treatment in advance.
The PCT panel meeting
The PCT will notify you about the panel meeting and it’s date, with a request for you and your clinicians to provide the information they need – which they will specify – and when they need it by. It is Vital that all the information is produced in time for the meeting, as panels often make decisions on the information they have.
There is no set procedure about who can attend panel meetings. Some PCTs allow the patient to attend either alone or with a “friend”. Some allow the clinicians and where relevant, the lawyers involved to attend. Others do not. Your PCT should set out in writing to you what the procedure is.
The framework for the meeting – in other words what they have to consider – also differs between PCTs, as each PCT has it’s own defined criteria for what should be considered as relevant. These criteria can differ remarkably between PCTs, so if you can. Write to them to find out what they are before you make your application.
The criteria usually involve clinical effectiveness, accessibility and, very importantly, some reference to cost effectiveness. They should also make reference to the application of the human rights act 1998.
To summerise:
• Get your consultant oncologist to write down what they advise as clinically recommended treatment for you and their reasons why you should have it.
• If you have been denied a treatment that your oncologist thinks you should get – e.g. Tarceva - apply in writing to your PCT enclosing your oncologists letter and preferably one from your GP
• Before you write, find out from the PCT what their criteria are and make sure you address them in your letter. If you get the criteria after you make your application, you can write a second letter, as long as they get it before the panel meeting
• Find out if you are allowed to attend the meeting and whom you can take along with you – e.g. a friend, clinician, lawyer. Make sure you provide the PCT with any information they need in time for the meeting.
If your application is refused
If the application is refused , ask the PCT for the full minuets of the meeting, the names of those on the panel and copies of all the information they had before them at their meeting. The freedom of information act helps here and you are entitled to copies of all your medical notes and records in any event.
AcknowledgementThis was very kindly sent to me from Ian Beuamont, Bowel Cancer UK. I spoke to him this am and told him I am campagning for Tarceva and he said I could use this information. It was put together by Barrister, Peter Telford.
Hope this helps you in some way.
Introduction
If you are a patient who’s been told by your oncologist that you could benefit from a particular drug, but your PCT won’t give it to you because it’s “too expensive” you can apply – with the help of your GP or Oncologist or both – to your primary care trust (PCT) For “exceptional funding” to pay for it.
A special PCT fund
PCT’s have to maintain a fund for exception cases, outside of their overall budget. In these cases, they cannot take into account whether the cost of the drug affects their overall budget – which is usually in deficit these days – or whether you the patient can afford to pay for the drug yourself.
When you can apply
An application for exceptional funding, which some PCTs call “special funding” or “special circumstances” can be made for drugs that haven’t been recommended – usually on the grounds of cost – by the National Institute for Health and Clinical Excellence (NICE). This currently applies, for example to biological agents such as Tarceva. NICE recommendations are guidance not law, so PCTs do not have to follow them.
An application can also be made in the cases where NICE hasn’t made a recommendation about a drug yet – either positive or negative – or about it’s use in a particular setting (e.g. first line combination with other treatments). In these circumstances, the PCT will have to decide if the drug can or cannot be prescribed.
Applications and appeals
The terms PCT’s use for applications can be confusing. Some applications are considered as just that and if refused they may be followed up by an appeal to an internal PCT panel. However, some PCTs refer to the initial application itself as an appeal, presumably because medical practitioners are told in advance not to apply for funding for patients. As they would be turned down anyway.
To make it even more confusing, some appeals can become fresh applications if new information about a case becomes available. In any event, you have the right to apply with the help of your GP or oncologist or both, and you should do so in writing. If you are too ill to peruse the application/appeal yourself, you can nominate someone to act on your behalf, but you should provide them with written confirmation that you give your permission in order to satisfy the PCT.
The PCTs response
There appears to be no set procedure followed by PCTs in responding to these applications, including in how long they take to reply. While there are some set deadlines, it appears that the PCTs treat each case individually and the more pressing or urgent the matter, the more likely they are to respond quickly.
On average, PCTs tend to respond to an application letter within a week. They then take up to a further two weeks to collect all the material they need and convene a panel of around five people to consider the application. However, that process can take up to six weeks in some more complicated cases and it is, of course, vital to get your medical practitioner’s written recommendation for the treatment in advance.
The PCT panel meeting
The PCT will notify you about the panel meeting and it’s date, with a request for you and your clinicians to provide the information they need – which they will specify – and when they need it by. It is Vital that all the information is produced in time for the meeting, as panels often make decisions on the information they have.
There is no set procedure about who can attend panel meetings. Some PCTs allow the patient to attend either alone or with a “friend”. Some allow the clinicians and where relevant, the lawyers involved to attend. Others do not. Your PCT should set out in writing to you what the procedure is.
The framework for the meeting – in other words what they have to consider – also differs between PCTs, as each PCT has it’s own defined criteria for what should be considered as relevant. These criteria can differ remarkably between PCTs, so if you can. Write to them to find out what they are before you make your application.
The criteria usually involve clinical effectiveness, accessibility and, very importantly, some reference to cost effectiveness. They should also make reference to the application of the human rights act 1998.
To summerise:
• Get your consultant oncologist to write down what they advise as clinically recommended treatment for you and their reasons why you should have it.
• If you have been denied a treatment that your oncologist thinks you should get – e.g. Tarceva - apply in writing to your PCT enclosing your oncologists letter and preferably one from your GP
• Before you write, find out from the PCT what their criteria are and make sure you address them in your letter. If you get the criteria after you make your application, you can write a second letter, as long as they get it before the panel meeting
• Find out if you are allowed to attend the meeting and whom you can take along with you – e.g. a friend, clinician, lawyer. Make sure you provide the PCT with any information they need in time for the meeting.
If your application is refused
If the application is refused , ask the PCT for the full minuets of the meeting, the names of those on the panel and copies of all the information they had before them at their meeting. The freedom of information act helps here and you are entitled to copies of all your medical notes and records in any event.
AcknowledgementThis was very kindly sent to me from Ian Beuamont, Bowel Cancer UK. I spoke to him this am and told him I am campagning for Tarceva and he said I could use this information. It was put together by Barrister, Peter Telford.
Hope this helps you in some way.